Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

AgeneBio Receives NIH Grant for Mild Cognitive Impairment Program Due to Alzheimer's Disease

americanpharmaceuticacreviewSeptember 15, 2017

Tag: AgeneBio , NIH Grant , Alzheimer's disease

PharmaSources Customer Service